Catalogs >
Cepheid >
Xpert® vanA/vanB

Xpert® vanA/vanB
4Pages

Catalog excerpts

Xpert® vanA/vanB 45-Minutes, Screen, detect, prevent, An accurate, rapid test to identity patients colonized with vancomycin-resistant enterococci (VRE). ^Ce C€ m In Vitro Diagnostic Medical Device A better way.

Open the catalog to page 1

THE NEED VRE: A growing concern Data from the European Antimicrobial Resistance Surveillance System indicates that infection rates with VRE are increasing, particularly in countries with high MRSA prevalence.2 • The proportion of invasive vancomycin-resistant Enterococcus faecium isolates reached 17% in Greece, 44% in Ireland, 23% in Portugal, 13% in the UK, and 16% in Germany2 • The percentage of vancomycin-resistant E. faecalis isolates from healthcare-associated infections varies from 4.2% in Spain to 17.8% in Portugal2 CDC, SHEA and WHO have put forward the following guidelines on how...

Open the catalog to page 2

© THE IMPACT With the GeneXpert® System you get both speed and accuracy in a single test cartridge. By providing the most efficient PCR test for VRE you will accelerate your laboratory's workflow with on-demand, random-access flexibility. Combining performance with the ability to run other tests (GBS, MRSA, C. difficile, Flu, etc.) will give you proven efficiency by having true menu consolidation on only one instrument, with less than 1 minute of hands-on time and actionable results in 45 minutes. Shift your lab from reactive to proactive • Receive a rapid result allowing for same day...

Open the catalog to page 3

3 EASY STEPS Total hands-on time: <1 Minute Insert swab into Sample Reagent vial and break Vortex and dispense Sample into Port S 3 Insert cartridge and start assay Xpert® vanA/vanB is a qualitative in vitro diagnostic test designed for rapid detection of vancomycin-resistance (vanA/vanB) genes. CATALOG NUMBER Xpert vanA/vanB (10 tests) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . GXVANA/B-CE-10 References: 1. Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob...

Open the catalog to page 4

Xpert® vanA/vanB 4Pages

Catalog excerpts

All Cepheid catalogs and technical brochures

Xpert® vanA/vanB
4Pages